Giving oral iron to patients with erythropoietic protoporphyria (EPP) who is iron deficient is thought to be beneficial. This is, however, not well documented. The purpose of this study is to investigate the effect and safety of oral iron in patients with EPP who is taking iron tablets due to iron deficiency.
Study Type
OBSERVATIONAL
Enrollment
10
Bispebjerg Hospital
Copenhagen, Denmark
Change in erythrocyte protoporphyrin concentration
Time frame: Before treatment and after 6-8 weeks of treatment
Change in hemoglobin and iron parameters
Time frame: Before treatment and after 6-8 weeks of treatment
Adverse event
Time frame: 6-8 weeks of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.